To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Perinatal stroke refers to strokes that occur between 20 weeks of gestation and 28 days postnatally, and it is increasingly recognized as a significant cause of neurologic complications such as cerebral palsy, epilepsy, and behavioral disorders, along with impaired visual and language development. The incidence of perinatal stroke is approximately 1 in 2,000 live births. This condition can be classified based on various criteria, including blood supply (venous or arterial), age at stroke (fetal or neonatal), and type (ischemic or hemorrhagic). Perinatal arterial ischemic stroke (PAIS) is defined by focal disruptions in cerebral blood flow arising from arterial issues or cerebral sinovenous thrombosis. PAIS is further categorized into fetal ischemic stroke, neonatal ischemic stroke, and presumed perinatal ischemic stroke, depending on the diagnosis timing. Perinatal hemorrhagic stroke is less defined but can also be categorized similarly to ischemic strokes.
Thrombophilia can be defined as laboratory abnormalities, usually in the coagulation system, that result in a hypercoagulable state and thus predispose to thrombosis. These abnormalities may be acquired or inherited. The most clearly established form of acquired thrombophilia is the antiphospholipid anti- body syndrome. This chapter focuses on inherited thrombophilia. The relevance of inherited thrombophilia in early pregnancy is manifested in an elevated risk of venous thromboembolism, a modestly increased risk of miscarriage, and a possible relation with fertility.
Accessory tricuspid valve is rare congenital abnormality. We describe a case of cryptogenic stroke in teenager boy caused by patent foramen ovale with thrombophilia and accessory tricuspid valve.
This chapter focuses on the various etiologies for intracerebral hemorrhage (CH), ischemic stroke (IS), transient ischemic attack (TIA), and cerebral venous sinus thrombosis (CVST) that are caused by blood disorders. Bleeding disorders may be inherited or acquired. They include thrombocytopenia and platelet function disorders, coagulation factor deficiencies, excessive anticoagulation and hemorrhagic complications after thrombolysis. Blood disorders associated with myeloproliferative diseases and disseminated intravascular coagulation (DIC) can cause both bleeding and thrombosis. Heparin-induced thrombocytopenia (HIT), the anti-phospholipid antibody syndrome, and thrombotic thrombocytopenic purpura (TTP) are conditions that cause thrombocytopenia but are more frequently responsible for thrombosis than for bleeding. Blood transfusion therapy is recommended as the most important intervention for primary stroke prevention and secondary stroke prevention in children with sickle cell disease. Cytoreduction with hydroxyurea reduces the incidence of thrombosis in essential thrombocythemia, and aspirin reduces the incidence of thrombotic events in polycythemia vera.
Venous thromboembolism (VTE) is a common cause of morbidity and mortality and has been implicated in the pathophysiology of a number of obstetric complications. This chapter provides an overview of the more common genetic thrombophilias and the acquired thrombophilia associated with the presence of antiphospholipid antibodies. A limited number of genetic variants are proven to be independent risk factors for VTE. These include mutations in the genes controlling the function of both pro- and anticoagulant factors. The main benefit in screening thrombophilia is to prevent a first VTE in affected relatives rather than secondary prevention of recurrent VTE. Oral contraceptives increase the risk of VTE, particularly in the first year of use. Women with thrombophilic defects are at greater risk. Improved pregnancy outcomes in women with antiphospholipid syndrome can be achieved with the use of aspirin and low-dose heparin.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.